Molecular diagnostics firm Cepheid (CPHD) up 6% AH as it gets FDA clearance for a test that...

|By:, SA News Editor

Molecular diagnostics firm Cepheid (CPHD) up 6% AH as it gets FDA clearance for a test that detects genetic variations related to an increased risk of blood clots. (PR)